Search

Search Language

Deutsch / German | Use language selector above (below, on mobile) to search additional languages

See by

Open filter

Selected filters
x(Client Results)

28 items matching filters

Search Results

Client Result

Orrick Advised Pattern Energy on the Sale of its Japan Assets, One of the Largest Deals Ever for a Renewable Energy Company in Japan

2 minute read | August.14.2023

Orrick advised Pattern Energy Group LP on the sale of its Japanese assets and 100% of its interest in Green Power Investment Corporation.

Client Result

Orrick Advises Green Street Power Partners on Sale of Majority Stake

2 minute read | April.12.2023

Orrick advised Green Street Power Partners on the sale of a majority equity interest to DIF Capital Partners.

Client Result

Orrick Advises on Redwood Software's Acquisition of Cerberus

2 minute read | February.03.2023

We advised Turn/River Capital on the acquisition by one of its portfolio companies, Redwood Software Inc., of Cerberus, LLC.

Client Result

Orrick Advises Catalyst Biosciences in Reverse Merger with GNI Group

1 minute read | December.28.2022

Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. in its acquisition of the F351 program, a ...

Client Result

Orrick Advises Superior Plus on its Acquisition of Low-Carbon Energy Solutions Provider Certarus

December.23.2022

Orrick advised Superior Plus on its acquisition of Certarus in a deal valued at CAD$1.05 billion.

Client Result

Orrick Advises Bayer on Partnership with Ginkgo Bioworks

October.17.2022

Orrick advised Bayer on its three-year strategic partnership with biotech company Ginkgo Bioworks to accelerate the research and development of ...

Client Result

Orrick Advises Ipsen on Acquisition of Epizyme

June.27.2022

The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.

Client Result

Orrick Represents 0x Labs on $70 Million Funding

April.27.2022

Orrick advised 0x Labs, a San Francisco-based open-source decentralized trade platform, on a $70M Series B financing, led by Greylock Partners.

Client Result

Orrick Advises Busuu on its US$436 Million Sale to Chegg

November.30.2021

Orrick is advising Busuu on its definitive agreement to be acquired by Chegg for approximately $436 million in an all-cash transaction.

Client Result

Orrick Advises Ladder on $100 Million Series D Round

October.04.2021

Congratulations to our client Ladder, a digital life insurance company, on its $100 million Series D financing round.

Client Result

Orrick Advises Opentrons Labworks on $200 Million Series C Round

September.24.2021

Opentrons will use this fundraising round to further invest in its automated lab platform globally.

Client Result

Orrick berät Lilium bei $3,3 Mrd. SPAC Merger, der Lilium an die NASDAQ bringt

September.15.2021

Orrick hat die Lilium GmbH, die sich als weltweit führendes Unternehmen im Bereich der regionalen elektrischen Luftmobilität positioniert hat, bei ...